Journal Updates
eMediNexus Coverage from: 
Why the Lower Risk of Prostate Cancer in Men With Diabetes?
eMediNexus,  07 November 2019
remove_red_eye 554 Views
#Hematology #Oncology #Pathology and Lab Medicine #Pharmacist #Urology

0 Read Comments                

Men with diabetes may appear to be at lower risk for prostate cancer because they are less likely to get a biopsy when they have elevated prostate-specific antigen (PSA), a large cohort study suggested.

The study, which included data on 564,666 men followed for 10 years, found that the likelihood of undergoing a biopsy after elevated PSA was lower among men receiving metformin (OR 0.87, 95% CI 0.80-0.96) and insulin (OR 0.83, 95% CI 0.74-0.93) compared with men without diabetes, reported Kerri Beckmann, PhD, of Kings College London, and colleagues in JAMA Network Open.

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now